Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Ironwood Pharmaceuticals Inc

3 Penny Stocks to Watch for Big Gains in 2025

The Federal Reserve's recent rate cut indicates a stable yet slowing economy, with inflation sticking around but consumer spending strong. In light of these events, penny stocks, Ribbon Communications (RBBN), Ironwood Pharmaceuticals (IRWD), and Organogenesis Holdings (ORGO), all priced under $5, could make attractive investments. Read on….

StockNews.com

3 High-Risk, High-Reward Penny Stocks to Buy

High-risk, high-reward stocks are highly favored by investors having high risk tolerance to achieve potential returns and yield. Hence, it could be ideal to buy fundamentally solid, high-risk, high-reward penny stocks Taboola.com (TBLA), Ironwood Pharmaceuticals (IRWD), and Castor Maritime (CTRM). Keep reading.

StockNews.com

Chart of the Day: Ironwood Pharma - Gastrointestinal Products

The Chart of the Day belongs to the gastrointestinal pharmaceutical products company Ironwood Pharmaceutical (IRWD) I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Buy These 3 Pharma Stocks in July

The pharmaceutical industry looks well-positioned for long term growth due to the globalization of the industry, increasing investments to develop life-saving drugs, rise in chronic diseases, and a rapidly aging population. To that end, it could be wise to buy fundamentally strong pharma stocks Amphastar Pharmaceuticals (AMPH), Ironwood Pharmaceuticals (IRWD),…

StockNews.com

3 Quality Medical Stocks to Explore

The medical industry is envisioned to remain afloat and thrive in the foreseeable future, thanks to advanced medical discoveries. Therefore, quality medical stocks Amphastar Pharmaceuticals (AMPH), Ironwood Pharmaceuticals (IRWD), and Voyager Therapeutics (VYGR) could be wise portfolio additions now. Read on….

StockNews.com

2 Pharma Stocks Investors Are Flocking

The pharmaceutical industry is expected to thrive amid robust demand and government support. Given the solid long-term prospects of the industry, investors should consider buying pharma stocks Ironwood Pharmaceuticals (IRWD) and Calliditas Therapeutics (CALT). Read on.

StockNews.com

2 Under-the-Radar Pharmaceutical Stocks to Add to Your Watchlist

Irrespective of worsening supply chain disruptions due to the Russia-Ukraine war, the pharmaceutical industry is expected to witness stable growth given the rising medical needs of an aging population and rapid advancements in the drug development process. So, amid an apparent resurgence of COVID-19 cases, we think it could be…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Jefferies Raises Price Target On This Small-Cap 'Stand Out' Biotech Stock

Ardelyx Inc (NASDAQ:ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1. Analyst Chris Howerton thinks Ardelyx "stands out" given that the Company has an approved IBS-C product, Isbrela, that will launch in April and whose commercial…

Benzinga

Ironwood Reports Mixed Q4 Results; Linzess Joins Blockbuster Club As US Sales Exceed $1B

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD)

Benzinga

People

Dipanjan BanchurSince

722 stories

Steve Reitmeister

480 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

117 stories

NVS

74 stories

Medical – Pharmaceuticals

Organogenesis Holdings Inc

Taro Pharmaceutical Industries Ltd

10 stories

TBLA

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.